Clinical Evaluation of Hemospray in Hemostasis of Active Variceal Bleeding

Clinical Evaluation of Hemospray in Hemostasis of Active Variceal Bleeding

The objective of this study is to assess the effectiveness of Hemospray in achieving initial hemostasis and decreased rate of re-bleeding in patients of acute variceal bleeding.

Inclusion criteria :

• 18 Years and older
• Bleeding Esophageal and / or Gastric varices

Exclusion Criteria:

• Patient is: < 18 years of age
• Unable to consent
• Contraindicated to undergo endoscopy,
• Already hospitalized for another illness
• Pregnant or lactating
• Patients with altered post-surgical anatomy of the stomach
• Previously placed intrahepatic portosystemic shunt
• Patient treated by other endoscopic or surgical modalities within 7 days prior to the intended application of Hemospray